LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bacterium and Viral Coinfection Contributes to Postinfectious Hydrocephalus

By LabMedica International staff writers
Posted on 12 Oct 2020
Print article
Image: Yellow color shows thiamine degradation on an agar plate of cultured Paenibacillus thiaminolyticus (Photo courtesy of Catherine A. Richter, PhD).
Image: Yellow color shows thiamine degradation on an agar plate of cultured Paenibacillus thiaminolyticus (Photo courtesy of Catherine A. Richter, PhD).
Neonatal sepsis often precedes postinfectious hydrocephalus (PIH), although the manifestations of hydrocephalus typically emerge in the months after the neonatal period as sufficient cerebrospinal fluid (CSF) accumulates such that cranial expansion garners medical attention.

Postinfectious hydrocephalus (PIH), is the most common cause of pediatric hydrocephalus worldwide, yet the microbial pathogens underlying this disease remain to be elucidated. Of the estimated 400,000 new cases each year, about half are estimated to be postinfectious, with the largest number of cases in low- and middle-income countries, especially sub-Saharan Africa.

A team of international scientists collaborating with the Columbia University's Mailman School of Public Health (New York, NY, USA) analyzed samples from 100 patients, 64 with post-infectious hydrocephalus (PIH) and 36 with non-post-infectious hydrocephalus (NPIH), all of whom were less than three months old who were seen at the CURE Children's Hospital of Uganda (Mbale, Uganda)

Blood was sampled with aseptic technique at the time of surgery, either at the time of catheter placement for an intravenous line or during venipuncture for routine laboratory testing. Cerebrospinal fluid (CSF) was obtained at the time of initial surgery. The team used both Sanger-based sequencing of bacterial 16S ribosomal DNA V1-V4 regions and next-generation sequencing of the V1-V2 and V4 regions. A broad screen for viral presence was performed in two different ways: VirCapSeq oligomer concentration and total RNA sequencing analysis. For the viruses that appeared abundant in either PIH or NPIH, polymerase chain reaction (PCR) confirmation was performed.

Using a targeted viral detection capture approach called VirCapSeqVERT, the investigators uncovered 11 viral strains across slightly more than a third of CSF samples. Cytomegalovirus was found among a portion of post-infectious hydrocephalus patients' CSF samples, but not among non-post-infectious hydrocephalus patients. Cytomegalovirus is a common virus that typically causes minor symptoms in adults but may lead to neurological damage in infants who acquire it early in life. The team grew three Paenibacillus isolates in culture and used whole-genome sequencing analysis to identify them as P. thiaminolyticus. V1-V4 Sanger sequencing of subcloned amplicons identified Paenibacillus as a predominant organism within the PIH cohort (23 of 64), but not within the NPIH cohort (0 of 36). A hybrid method was used to reconstruct the genome of a P. thiaminolyticus isolate, combining short-read sequencing, optical mapping (Bionano Genomics, San Diego, CA, USA), and nanopore long contiguous sequencing (MinION, Oxford Nanopore Technologies, Oxford, UK).

The authors concluded that their findings showed that an unbiased pan-microbial approach enabled characterization of Paenibacillus in CSF samples from PIH cases, and point toward a pathway of more optimal treatment and prevention for PIH and other proximate neonatal infections.

Edith Mbabazi-Kabachelor, MD, MPH, director of research at CURE Children's Hospital of Uganda and a co-author of the study, said, “Hydrocephalus is the most common childhood neurosurgical condition that we see in the population that we serve. If hydrocephalus is left untreated in children less than two years old, the progressive increase in head size will lead to further brain damage, resulting in the majority of these children dying, and those that survive being left with severe cognitive and physical disability.” The study was published on September 30, 2020 in the journal Science Translational Medicine.

Related Links:
Columbia University's Mailman School of Public Health
CURE Children's Hospital of Uganda
Bionano Genomics
Oxford Nanopore Technologies


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.